19 Companies Pioneering AI Foundation Models in Pharma and Biotech
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As …
#AI in Healthcare
Bioptimus Introduces H-optimus-0: An Open-Source AI Model for Pathology
French startup Bioptimus has released H-optimus-0, the largest open-source AI foundation model for pathology. With 1.1 billion parameters, this model …
OMNY Health Partners with QuantHealth and ArisGlobal to Enhance AI-Driven Healthcare Solutions
OMNY Health, a healthcare ecosystem specializing in compliant cross-industry data sharing, has launched a platform designed to support AI-driven health …
Cromatic Launches AI-Powered 'Sourcerer' for Streamlined R&D Outsourcing in Life Sciences
Cromatic, a startup focused on life sciences research outsourcing, has introduced an AI-powered tool named Sourcerer. This tool is designed …
Lokavant Introduces AI Solution for Comprehensive Clinical Trial Optimization
Lokavant has unveiled Spectrum, an AI software solution designed to enhance clinical trial feasibility and optimization throughout the entire clinical …
New LENSai API by BioStrand Integrates Large Language Models with Health Data for Advanced Drug Development
BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd. (IPA), has launched its new LENSai API software, designed to integrate large databases …
FDA and CluePoints Extend Collaboration to Enhance Clinical Trial Data Integrity with AI and Machine Learning
The Food and Drug Administration (FDA) and CluePoints, a provider of statistical and AI-driven software solutions, have entered a new …
Tempus AI Files S-1 Registration to Go Public
Tempus AI has officially filed its S-1 registration statement with the Securities and Exchange Commission (SEC), marking a significant step …
Sanofi, Formation Bio, and OpenAI Partner to Innovate Drug Development with AI
Sanofi, Formation Bio, and OpenAI have announced a pioneering collaboration aimed at accelerating drug development using artificial intelligence (AI). This …
Insilico Medicine Unveils nach0: A Comprehensive LLM for Chemical and Biomedical Applications
Insilico Medicine, a clinical-stage AI-driven drug discovery company, in collaboration with NVIDIA, has introduced nach0, a novel large language model …
Accenture's Investment in Turbine Enhances AI-Powered Cell Simulations for Biopharma R&D
Accenture has strategically invested in Turbine, a company specializing in predictive simulation with a platform aimed at interpreting human biology. …
Insilico Medicine Initiates Phase I Clinical Trial for Novel QPCTL Inhibitor
Insilico Medicine, a biotechnology company specializing in generative artificial intelligence, has begun dosing patients in the first clinical trial for …